This mechanism may be particularly relevant in prostate cancer, given the reduced levels of p27, an inhibitor of CDK2, and increased levels of CDK2 and cyclin E have been known to be indicators of poor prognosis and associated with androgen independence in prostate cancer for several decades [107,108]. The gene discussed is CDK2; the disease is prostate carcinoma.